![Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920313239-gr1.jpg)
Safety and activity of varlilumab, a novel and first-in-class agonist anti- CD27 antibody, for hematologic malignancies - ScienceDirect
![Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt.15.32/asset/images/medium/figure1.gif)
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy
![The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13046-021-02215-y/MediaObjects/13046_2021_2215_Fig1_HTML.png)
The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text
![Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation](https://www.frontiersin.org/files/Articles/715909/fimmu-12-715909-HTML-r1/image_m/fimmu-12-715909-g002.jpg)
Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
![High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease | Journal of the American Heart Association High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/efa7bcd1-7750-4ecf-a14d-18a772cd6dba/jah32507-fig-0001.gif)
High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease | Journal of the American Heart Association
![The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720301765-fx1.jpg)
The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory - ScienceDirect
![CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-1097-8/MediaObjects/42003_2020_1097_Fig1_HTML.png)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
![CD27 expression on Treg cells limits immune responses against tumors | Journal of Molecular Medicine CD27 expression on Treg cells limits immune responses against tumors | Journal of Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00109-021-02116-9/MediaObjects/109_2021_2116_Fig7_HTML.png)
CD27 expression on Treg cells limits immune responses against tumors | Journal of Molecular Medicine
![CD27 – IgD naı¨venaı¨ve B cells are induced to produce IgM by TLR-9... | Download Scientific Diagram CD27 – IgD naı¨venaı¨ve B cells are induced to produce IgM by TLR-9... | Download Scientific Diagram](https://www.researchgate.net/profile/Irene-Libri/publication/24376319/figure/fig1/AS:340667906707466@1458232966967/CD27-IgD-naivenaive-B-cells-are-induced-to-produce-IgM-by-TLR-9-stimulation-and_Q320.jpg)
CD27 – IgD naı¨venaı¨ve B cells are induced to produce IgM by TLR-9... | Download Scientific Diagram
![CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42003-020-1097-8/MediaObjects/42003_2020_1097_Fig5_HTML.png)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
![Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation Frontiers | Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation](https://www.frontiersin.org/files/Articles/715909/fimmu-12-715909-HTML-r1/image_m/fimmu-12-715909-g001.jpg)